home / stock / lbtsf / lbtsf news

LBTSF News and Press, Almirall Sa Ord From 10/09/19

Stock Information
Company Name: Almirall Sa Ord
Stock Symbol: LBTSF
Market: OTC
Menu
LBTSF LBTSF Quote LBTSF Short LBTSF News LBTSF Articles LBTSF Message Board
Get LBTSF Alerts

News, Short Squeeze, Breakout and More Instantly...
LBTSF - Dermira up 3% premarket on start of late-stage development of lebrikizumab

Dosing is underway in a Phase 3 clinical trial evaluating Dermira's (NASDAQ: DERM ) lebrikizumab, an IL-13 inhibitor, in patients at least 12 years old with moderate-to-severe atopic dermatitis (AD). More news on: Dermira, Inc., Almirall, S.A., Healthcare stocks news, Stocks on the move...
LBTSF - Almirall's (LBTSF) CEO Peter Guenter on Half Year 2019 Results - Earnings Call Transcript

Almirall, S.A. (LBTSF) Half Year 2019 Earnings Conference Call July 29 2019, 4:00 AM ET Company Participants Pablo Divasson del Fraile – Head of Investor Relations Peter Guenter – Chief Executive Officer David Nieto – Executive Vice President and Chief Financ...

LBTSF - Almirall, S.A. 2019 Q2 - Results - Earnings Call Slides

The following slide deck was published by Almirall, S.A. in conjunction with their 2019 Q2 earnings Read more ...

LBTSF - Almirall, S.A. reports 1H results

Almirall, S.A. ( OTC:LBTSF ): 1H net income of €62M More news on: Almirall, S.A., Earnings news and commentary, Healthcare stocks news, Read more ...

LBTSF - Almirall's (LBTSF) CEO Peter Guenter on Q1 2019 Results - Earnings Call Transcript

Almirall, S.A (LBTSF) Q1 2019 Earnings Conference Call May 13, 2019 4:00 AM ET Company Participants Pablo Divasson del Fraile – Head of Investor Relations Peter Guenter – Chief Executive Officer David Nieto – Executive Vice President and Chief Financial Offic...

LBTSF - Almirall, S.A. 2019 Q1 - Results - Earnings Call Slides

The following slide deck was published by Almirall, S.A. in conjunction with their 2019 Q1 earnings Read more ...

LBTSF - Almirall, S.A. reports Q1 results

Almirall, S.A. ( OTC:LBTSF ): Q1 Normalized Net Income of €32.6M More news on: Almirall, S.A., Earnings news and commentary, Healthcare stocks news, Read more ...

LBTSF - Paratek: Will Nuzyra Succeed?

In October 2018, Paratek Pharmaceuticals ( PRTK ) received FDA approvals for its two main products - SEYSARA and NUZYRA. The company also entered into an exclusive licensing agreement with Almirall ( LBTSF ) for the development and commercialization rights of SEYSARA, which was launched in the...

LBTSF - Almirall's (LBTSF) CEO Peter Guenter on Full Year 2018 Results - Earnings Call Transcript

Almirall SA (LBTSF) Full Year 2018 Earnings Conference Call February 25, 2019, 4:00 AM ET Company Participants Pablo Divasson del Fraile – Head of Investor Relations Peter Guenter – Chief Executive Officer Ron Menezes – GM of Almirall U.S. David Nieto ...

LBTSF - Almirall SA 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Almirall SA in conjunction with their 2018 Q4 earnings Read more ...

Previous 10 Next 10